Eiger BioPharmaceuticals (EIGR) Q4 2022 Earnings

16MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.64
-0.6
-0.55
-0.51

Details

Expected EPS
-0.54
Actual EPS
-0.57
Surprise EPS
-0.03
Surprise Percent
+5.56%

Description

Eiger BioPharmaceuticals (EIGR) has reported earnings of -0.57 per share for Q4 2022.

0 Comments

Share your thoughts